Upper gastrointestinal bleeding epidemiology and demographics

Revision as of 22:02, 13 December 2017 by Aditya Ganti (talk | contribs) (→‎Gender)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Upper gastrointestinal bleeding Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Upper Gastrointestinal Bleeding from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Management

Initial resuscitation
Pharmacotherapy
Risk stratification

Surgery

Surgical Management
Endoscopic Intervention

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Upper gastrointestinal bleeding epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Upper gastrointestinal bleeding epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Upper gastrointestinal bleeding epidemiology and demographics

CDC on Upper gastrointestinal bleeding epidemiology and demographics

Upper gastrointestinal bleeding epidemiology and demographics in the news

Blogs on Upper gastrointestinal bleeding epidemiology and demographics

Directions to Hospitals Treating Upper gastrointestinal bleeding

Risk calculators and risk factors for Upper gastrointestinal bleeding epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

About 75% of patients presenting to the emergency room with upper gastrointestinal bleeding (UGIB) have an upper source. The diagnosis is easier when the patient has hematemesis. In the absence of hematemesis, 40% to 50% of patients in the emergency room with GI bleeding have an upper source. The incidence of acute UGIB is approximately 50 to 100 per 100,000 individuals worldwide. Patients of all age groups may develop upper gastrointestinal bleeding. Males are more commonly affected by UGIB than females.

Epidemiology

Incidence

  • The incidence of acute upper gastrointestinal bleeding (UGIB) is approximately 50 to 100 per 100,000 individuals worldwide.[1][2]
  • Approximately 100,000 patients are admitted to US hospitals for therapy for UGIB.

Prevalence

  • The prevalence of UGIB is almost the same as incidence, as it is a medical emergency and is not a chronic disease.

Age

  • Patients of all age groups may develop upper gastrointestinal bleeding.
  • The population with UGIB has become progressively older, with a concurrent increase in significant comorbidities that increase mortality.
  • Mortality increases with older age (>60 y), in both males and females.

Race

There is no racial predilection to upper gastrointestinal bleeding.

Gender

  • Upper gastrointestinal bleeding is more common in males than females.
  • The males to female ratio is approximately 2 to 1.

References

  1. El-Tawil AM (2012). "Trends on gastrointestinal bleeding and mortality: where are we standing?". World J. Gastroenterol. 18 (11): 1154–8. doi:10.3748/wjg.v18.i11.1154. PMC 3309903. PMID 22468077.
  2. van Leerdam ME (2008). "Epidemiology of acute upper gastrointestinal bleeding". Best Pract Res Clin Gastroenterol. 22 (2): 209–24. doi:10.1016/j.bpg.2007.10.011. PMID 18346679.


Template:WikiDoc Sources